CD4 and metabolic dysfunction-associated steatotic liver disease: This previous report showed that in nonalcoholic fatty liver disease, intrahepatic CD4+ T cells in humans and mice are selectively impaired by the accumulation of mitochondria-derived ROS induced by high volumes of fatty acids, which contributes to hepatocellular carcinoma progression.